174 related articles for article (PubMed ID: 29529503)
21. IRAK-4 inhibitors. Part 1: a series of amides.
Buckley GM; Gowers L; Higueruelo AP; Jenkins K; Mack SR; Morgan T; Parry DM; Pitt WR; Rausch O; Richard MD; Sabin V; Fraser JL
Bioorg Med Chem Lett; 2008 Jun; 18(11):3211-4. PubMed ID: 18474425
[TBL] [Abstract][Full Text] [Related]
22. Small molecule KDM4s inhibitors as anti-cancer agents.
Lin H; Li Q; Li Q; Zhu J; Gu K; Jiang X; Hu Q; Feng F; Qu W; Chen Y; Sun H
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):777-793. PubMed ID: 29651880
[TBL] [Abstract][Full Text] [Related]
23. Discovery of USP7 small-molecule allosteric inhibitors.
Engström O; Belda O; Kullman-Magnusson M; Rapp M; Böhm K; Paul R; Henderson I; Derbyshire D; Karlström S; Parkes KEB; Zhao H
Bioorg Med Chem Lett; 2020 Oct; 30(20):127471. PubMed ID: 32781219
[TBL] [Abstract][Full Text] [Related]
24. Identification of small molecule sphingomyelin synthase inhibitors.
Deng X; Lin F; Zhang Y; Li Y; Zhou L; Lou B; Li Y; Dong J; Ding T; Jiang X; Wang R; Ye D
Eur J Med Chem; 2014 Feb; 73():1-7. PubMed ID: 24374347
[TBL] [Abstract][Full Text] [Related]
25. Identification of small molecule inhibitors of human COQ7.
Tsuganezawa K; Sekimata K; Nakagawa Y; Utata R; Nakamura K; Ogawa N; Koyama H; Shirouzu M; Fukami T; Kita K; Tanaka A
Bioorg Med Chem; 2020 Jan; 28(1):115182. PubMed ID: 31753803
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis and biological evaluation of small molecules as potent glucosidase inhibitors.
Hati S; Madurkar SM; Bathula C; Thulluri C; Agarwal R; Siddiqui FA; Dangi P; Adepally U; Singh A; Singh S; Sen S
Eur J Med Chem; 2015 Jul; 100():188-96. PubMed ID: 26087029
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and Structural Characterization of Ricin Inhibitors Targeting Ribosome Binding Using Fragment-Based Methods and Structure-Based Design.
Li XP; Harijan RK; Cao B; Kahn JN; Pierce M; Tsymbal AM; Roberge JY; Augeri D; Tumer NE
J Med Chem; 2021 Oct; 64(20):15334-15348. PubMed ID: 34648707
[TBL] [Abstract][Full Text] [Related]
28. The Inhibitory Effects of 6-Thioguanine and 6-Mercaptopurine on the USP2a Target Fatty Acid Synthase in Human Submaxillary Carcinoma Cells.
Cheng CP; Liu ST; Chiu YL; Huang SM; Ho CL
Front Oncol; 2021; 11():749661. PubMed ID: 34956872
[TBL] [Abstract][Full Text] [Related]
29. Ubiquitin-specific protease 2a stabilizes MDM4 and facilitates the p53-mediated intrinsic apoptotic pathway in glioblastoma.
Wang CL; Wang JY; Liu ZY; Ma XM; Wang XW; Jin H; Zhang XP; Fu D; Hou LJ; Lu YC
Carcinogenesis; 2014 Jul; 35(7):1500-9. PubMed ID: 24445145
[TBL] [Abstract][Full Text] [Related]
30. The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer.
Graner E; Tang D; Rossi S; Baron A; Migita T; Weinstein LJ; Lechpammer M; Huesken D; Zimmermann J; Signoretti S; Loda M
Cancer Cell; 2004 Mar; 5(3):253-61. PubMed ID: 15050917
[TBL] [Abstract][Full Text] [Related]
31. USP2a negatively regulates IL-1β- and virus-induced NF-κB activation by deubiquitinating TRAF6.
He X; Li Y; Li C; Liu LJ; Zhang XD; Liu Y; Shu HB
J Mol Cell Biol; 2013 Feb; 5(1):39-47. PubMed ID: 22611252
[TBL] [Abstract][Full Text] [Related]
32. Discovery of small molecule inhibitors of human uridine-cytidine kinase 2 by high-throughput screening.
Okesli-Armlovich A; Gupta A; Jimenez M; Auld D; Liu Q; Bassik MC; Khosla C
Bioorg Med Chem Lett; 2019 Sep; 29(18):2559-2564. PubMed ID: 31420268
[TBL] [Abstract][Full Text] [Related]
33. Repositioning the substrate activity screening (SAS) approach as a fragment-based method for identification of weak binders.
Gladysz R; Cleenewerck M; Joossens J; Lambeir AM; Augustyns K; Van der Veken P
Chembiochem; 2014 Oct; 15(15):2238-47. PubMed ID: 25154878
[TBL] [Abstract][Full Text] [Related]
34. The mimics of N
Wang C; Wang F; Chen X; Zou Y; Zhu H; Zhao Q; Shen J; Li Y; Li Y; He B
Bioorg Med Chem Lett; 2018 Aug; 28(14):2375-2378. PubMed ID: 29921476
[TBL] [Abstract][Full Text] [Related]
35. Identification and characterization of a new chemotype of noncovalent SENP inhibitors.
Madu IG; Namanja AT; Su Y; Wong S; Li YJ; Chen Y
ACS Chem Biol; 2013 Jul; 8(7):1435-41. PubMed ID: 23614497
[TBL] [Abstract][Full Text] [Related]
36. Ubiquitin-specific peptidase 2a (USP2a) deubiquitinates and stabilizes β-catenin.
Kim J; Alavi Naini F; Sun Y; Ma L
Am J Cancer Res; 2018; 8(9):1823-1836. PubMed ID: 30323974
[TBL] [Abstract][Full Text] [Related]
37. Discovery of d-amino acid oxidase inhibitors based on virtual screening against the lid-open enzyme conformation.
Szilágyi B; Skok Ž; Rácz A; Frlan R; Ferenczy GG; Ilaš J; Keserű GM
Bioorg Med Chem Lett; 2018 Jun; 28(10):1693-1698. PubMed ID: 29699925
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis and biological evaluation studies of novel small molecule ENPP1 inhibitors for cancer immunotherapy.
Gangar M; Goyal S; Raykar D; Khurana P; Martis AM; Goswami A; Ghoshal I; Patel KV; Nagare Y; Raikar S; Mukherjee A; Cyriac R; Paquin JF; Kulkarni A
Bioorg Chem; 2022 Feb; 119():105549. PubMed ID: 34929517
[TBL] [Abstract][Full Text] [Related]
39. Selective, Small-Molecule Co-Factor Binding Site Inhibition of a Su(var)3-9, Enhancer of Zeste, Trithorax Domain Containing Lysine Methyltransferase.
Taylor AP; Swewczyk M; Kennedy S; Trush VV; Wu H; Zeng H; Dong A; Ferreira de Freitas R; Tatlock J; Kumpf RA; Wythes M; Casimiro-Garcia A; Denny RA; Parikh MD; Li F; Barsyte-Lovejoy D; Schapira M; Vedadi M; Brown PJ; Arrowsmith CH; Owen DR
J Med Chem; 2019 Sep; 62(17):7669-7683. PubMed ID: 31415173
[TBL] [Abstract][Full Text] [Related]
40. Identification of B. anthracis N(5)-carboxyaminoimidazole ribonucleotide mutase (PurE) active site binding compounds via fragment library screening.
Lei H; Jones C; Zhu T; Patel K; Wolf NM; Fung LW; Lee H; Johnson ME
Bioorg Med Chem; 2016 Feb; 24(4):596-605. PubMed ID: 26740153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
